Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac versus pethidine for postoperative pain after pelvic reconstructive surgery
IRCT20220620055225N4Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ketorolac, pethidine and acetaminophen in postoperative pain, pelvic pain and perineal pain (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Patient pain level and Amount of pethidine needed. Started Sep 2025; status: recruiting.
02
Drugs
ketorolacpethidineacetaminophen
03
Conditions
postoperative painpelvic painperineal pain
Beyond the preview
Go deeper on IRCT20220620055225N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220620055225N4.